Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 3077-3083, June 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mobbs, B. G.
Right arrow Articles by Johnson, I. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mobbs, B. G.
Right arrow Articles by Johnson, I. E.

Basal and Estrogen-stimulated Hormone Receptor Profiles in Four R3327 Rat Prostatic Carcinoma Sublines in Relation to Histopathology and Androgen Sensitivity1

Betty G. Mobbs and Ivy E. Johnson

Department of Surgery, University of Toronto, Toronto, Ontario, M5S 1A8, Canada

Four sublines (H, HI, G, and AT) of the R3327 (Dunning) rat prostatic carcinoma have different androgen sensitivities and histopathological characteristics. In order to investigate whether these characteristics were associated with differences in the hormone receptor profile and its response to estrogen, we carried out Scatchard analysis on the cytosolic (C) and high-salt nuclear-associated (N) androgen (AR), estrogen (ER), and progesterone (PgR) receptor in each line, carried in control and diethylstilbestrol (DES)-treated animals. In the H line (androgen sensitive, well differentiated) DES treatment resulted in significant increases in total cellular AR and ER, in redistribution of both receptors between the C and N fractions, and in a marked increased of PgR (>10-fold). The hormone receptor profile and its response to DES was similar in the HI line (androgen insensitive, well differentiated), except that total cellular ER was not increased after treatment. The G line (androgen sensitive, poorly differentiated) contained higher basal concentrations of AR and PgR than the H line, but the concentrations were not increased by DES treatment, although treatment promoted association of ER with the nuclear fraction. The AT line (androgen insensitive, anaplastic) contained no ER and negligible PgR, but AR was present, although in lower concentrations than in the other lines. Diethylstilbestrol treatment had no effect on the concentration, although redistribution of AR between C and N fractions did occur. Some characteristics of the AR in the AT line differed qualitatively from that in the H line, but injection of testosterone into castrated animals bearing the AT tumor promoted association of AR with the nuclear fraction, indicating normal activation.

The data suggest that the ability of DES treatment to increase AR and PgR concentrations is associated with differentiation and/or the presence of stroma and that it is unrelated to androgen sensitivity.

1 Supported by a grant from the National Cancer Institute of Canada.

Received 8/25/87. Revised 2/ 1/88. Accepted 2/26/88.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.